Brief: Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
14/01/2025 14:22
Jan 14 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O :
* ACADIA PHARMACEUTICALS PROVIDES BUSINESS AND PIPELINE
UPDATES AT
43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
* ACADIA PHARMACEUTICALS INC: ANNUAL NET SALES FOR FULL-YEAR
2025
EXPECTED TO EXCEED $1 BILLION
* ACADIA PHARMACEUTICALS: MARKETING AUTHORIZATION
APPLICATION FOR
DAYBUE SUBMITTED TO EMA
Source text: ID:nBw9YXYGNa
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP